Angiodynamics to report fiscal 2025 second quarter financial results on january 8, 2025 and host virtual nanoknife investor event

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the second quarter of fiscal year 2025 before the market open on wednesday, january 8, 2025, followed by a virtual nanoknife system investor event. fiscal 2025 second quarte.
ANGO Ratings Summary
ANGO Quant Ranking